Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Girls should have prescription for 5-days-after pill - Pani

Girls should have prescription for 5-days-after pill - Pani

AIFA chief doesn't see pregnancy test as necessary

Rome, 17 February 2015, 14:21

ANSA Editorial

ANSACheck

Luca Pani, the director general of Italian Pharmaceuticals Agency AIFA, said Tuesday that he thought girls under-18 should have a doctor's prescription to obtain the so-called 'five-days-after' emergency contraception pill. "My personal opinion is that the health of women, above all minors, must be protected," Pani said when commenting on the five-days-after pill. "I think it would have much sense (requiring) a pregnancy test. But I see the absence of a prescription for minors as problematic". Last month AIFA started assessing whether to make the five-days-after pill available without a prescription.
    The pill prevents unwanted pregnancies by delaying or preventing ovulation if taken within 120 hours, or five days, of unprotected intercourse.
    In 2011, the health ministry's superior council on health said the pill should be marketed as an emergency contraceptive, but only to women who can prove they are not already pregnant.
    The contraceptive manufactured by HRA Pharma was approved in Europe as a prescription medication at the end of 2009.
    A survey of 134,000 women by VediamociChiara women's health online magazine showed 93% of respondents believed they should be able to access emergency contraception without a prescription.
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.